Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma

Clinical trial NCT06580054 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06580054
Sponsor: University of Michigan Rogel Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

Start date: 2025-03-05
Primary completion: 2026-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.